apl. Prof. Dr. Sabine Semrau

Medizinische Fakultät

Radiotherapy for the elderly Patient with Head and Neck Squamous Cell Carcinoma - Experience of a Center for ENT-Tumors (2021) Winkler LS, Lettmaier S, Semrau S, Müller SK, Traxdorf M, Iro H, Kesting MR, et al. Conference contribution Progress Patterns under Radioimmunotherapy - clinical Evaluation of the prospective STICI Study (2021) Schubert P, Schweizer C, Roesch J, Haderlein M, Rutzner S, Semrau S, Donaubauer AJ, et al. Conference contribution Primary results of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma (HNSCC) with double checkpoint blockade and radiotherapy dependent on intratumoral CD8+T-cell infiltration. (2021) Hecht M, Eckstein M, Rutzner S, von der Grün J, Illmer T, Klautke G, Laban S, et al. Conference contribution Implementation of double immune checkpoint blockade increases response rate to induction chemotherapy in head and neck cancer (2021) Semrau S, Gostian AO, Traxdorf M, Eckstein M, Rutzner S, von der Grün J, Illmer T, et al. Journal article High-grade salivary gland cancer: is surgery followed by radiotherapy an adequate treatment to reach tumor control? Results from a tertiary referral centre focussing on incidence and management of distant metastases (2021) Freitag V, Lettmaier S, Semrau S, Hecht M, Mantsopoulos K, Müller-Hübner SKU, Traxdorf M, et al. Journal article NSD3-NUTM1-rearranged carcinoma of the median neck/thyroid bed developing after recent thyroidectomy for sclerosing mucoepidermoid carcinoma with eosinophilia: report of an extraordinary case (2021) Agaimy A, Tögel L, Stöhr R, Meidenbauer N, Semrau S, Hartmann A, Mantsopoulos K Journal article The role of plastic reconstructive surgery in surgical therapy of soft tissue sarcomas (2020) Götzl R, Sterzinger S, Arkudas A, Boos A, Semrau S, Vassos N, Grützmann R, et al. Journal article Reactivation of HCMV during RT of the brain results in critical illness and early mortality (2020) Frey B, Goerig N, Becker I, Donaubauer AJ, Korn K, Überla K, Schmidt M, et al. Conference contribution Prospective evaluation of the prognostic value of immune-related adverse events in patients with non-melanoma solid tumour treated with PD-1/PD-L1 inhibitors alone and in combination with radiotherapy (2020) Schweizer C, Schubert P, Rutzner S, Eckstein M, Haderlein M, Lettmaier S, Semrau S, et al. Journal article Prospective Evaluation of All-lesion Versus Single-lesion Radiotherapy in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors (2020) Schubert P, Rutzner S, Eckstein M, Frey B, Schweizer C, Haderlein M, Lettmaier S, et al. Journal article